GlassScriptPhysician profile
Na Chou
NPI 1114465176
$2,118.18
in general payments reported to CMS, 2019-2025
22 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $1,463 · 2023: $178 · 2024: $23.19 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $601.63 | 2021-2022 | |
| Abbvie INC. | $356.24 | 2022-2025 | |
| Astellas Pharma US INC | $327.55 | 2021-2023 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $154.28 | 2022 | |
| Endo Pharmaceuticals INC. | $125.42 | 2021-2022 | |
| Janssen Biotech, INC. | $81.89 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $72.23 | 2022 | |
| 180 Medical, INC. | $53.72 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $44.53 | 2021-2022 | |
| Hollister Incorporated | $41.40 | 2021-2022 | |
| Teleflex LLC | $36.76 | 2022 | |
| Progenics Pharmaceuticals, INC. | $33.33 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $32.31 | 2023 | Gemtesa |
| Olympus America INC. | $23.48 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.65 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $21.01 | 2021 | |
| Antares Pharma, INC. | $19.95 | 2021 | |
| Clarus Therapeutics INC. | $15.62 | 2021 | |
| Urogen Pharma, INC. | $15.40 | 2023 | |
| Photocure INC | $15.12 | 2021 | |
| Coloplast Corp | $12.77 | 2021 | |
| Axonics, INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Na Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.